BMS-066 is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets IKKβ and TYK2.
Molecular Weight
379.42
Molecular Formula
C19H21N7O2
Targets
IKKβ: 9 nM; TYK2: 72 nM
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
BMS-066 can be used to study its potential as a JAK2 inhibitor in various cancers and immune disorders.
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.